ATELLICA™ CH METHADONE METABOLITE
EL ENSAYO ATELLICATM CH METHADONE METABOLITE (EDDP) (METMTB) ES PARA USO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUALITATIVA DE LOS METABOLITOS DE METADONA EN ORINA HUMANA. EL ENSAYO METMTB SOLAMENTE BRINDA UN RESULTADO DE PRUEBA PRELIMINAR. EL CALIBRA
THE ATELLICATM CH METHADONE METABOLITE (EDDP) ASSAY (METMTB) IS FOR IN VITRO DIAGNOSTIC USE IN THE QUALITATIVE DETERMINATION OF METHADONE METABOLITES IN HUMAN URINE. THE METMTB ASSAY PROVIDES ONLY A PRELIMINARY TEST RESULT. THE CALIBRA
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓN DE METABOLITOS DE METADONA
- Trade Name (English)
- ASSAY FOR THE DETERMINATION OF METABOLITES OF METHADONE
- Analysis ID
- 1332R2018 SSA
- Registration Date
- June 04, 2018
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.
Access comprehensive regulatory information for ATELLICA™ CH METHADONE METABOLITE (ATELLICA™ CH METHADONE METABOLITE) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1332R2018 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on June 04, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.